October 8, 2020
9:00am PT | 12:00pm ET
Digital therapeutics (DTx) is reshaping the landscape of chronic disease management and care, enabling patients to leverage technology to take control of their own health. DTx is the convergence of healthcare and software. These technological advancements allow providers and customers to engage in new, innovative ways.
The global digital therapeutics market is expected to grow to $6.9 billion by 2025. This exponential growth gives life science companies the opportunity to lead the next generation of care management and shape the future of healthcare. Now that the benefits of DTx are becoming clearer the industry is rapidly moving towards the commercialization of these solutions.
Join us for a virtual panel discussion where we will assess the growth of the industry so far, share best practices for DTx commercialization and look towards the next phases of industry growth.